Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 7;4(1):10-14.
doi: 10.1016/j.adro.2018.08.025. eCollection 2019 Jan-Mar.

Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report

Adam R Wolfe  1 , Rishi Jain  2 , Timothy M Pawlik  3 , Jon Walker  4 , Terence M Williams  1
Affiliations
Case Reports

Radiation-Induced Colitis in a Pancreatic Cancer Patient With a Germline BRCA2 Mutation: A Case Report

Adam R Wolfe et al. Adv Radiat Oncol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Axial view of computed tomography scan of the abdomen before chemoradiation therapy. Pancreatic tumor abutted but did not encase the hepatic artery, portal splenic confluence, or superior mesenteric artery.
Figure 2
Figure 2
Radiation treatment plan (planned for a total dose of 55 Gy in 25 fractions with concurrent 5-flourouracil). (A) Axial slice showing radiation dose overlapping the transverse colon. (B) Coronal image of radiation plan. Large areas of overlap between treatment planning target volume and large bowel.
Figure 3
Figure 3
Coronal view from computed tomography scan of the abdomen after radiation therapy. Note pancolonic wall thickening with adjacent inflammatory changes compatible with an acute inflammatory colitis.
Figure 4
Figure 4
Colonoscopy showing mucosa with punctate hemorrhages, ulceration, and increased friability with contact.
See this image and copyright information in PMC

References

    1. Katz M.H.G., Marsh R., Herman J.M. Borderline resectable pancreatic cancer: Need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013;20:2787–2795. - PMC - PubMed
    1. Katz M.H.G., Pisters P.W., Evans D.B. Borderline resectable pancreatic cancer: The importance of this emerging stage of disease. J Am Coll Surg. 2008;206:833–848. - PMC - PubMed
    1. Stokes J.B., Nolan N.J., Stelow E.B. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol. 2011;18:619–627. - PubMed
    1. Lee J.-L., Kim S.C., Kim S.E. Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. Surgery. 2012;152:851–862. - PubMed
    1. Takahashi H., Ohigashi H., Gotoh K. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Ann Surg. 2013;258:1040–1050. - PubMed

Publication types

LinkOut - more resources